Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 8 studies | 18% ± 3% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 17% ± 2% | |
endothelial cell | 6 studies | 26% ± 7% | |
B cell | 5 studies | 18% ± 3% | |
epithelial cell | 5 studies | 30% ± 11% | |
classical monocyte | 3 studies | 24% ± 7% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
hematopoietic precursor cell | 3 studies | 20% ± 7% | |
non-classical monocyte | 3 studies | 25% ± 6% | |
neuron | 3 studies | 28% ± 9% | |
retinal ganglion cell | 3 studies | 53% ± 26% | |
retina horizontal cell | 3 studies | 28% ± 9% | |
fibroblast | 3 studies | 24% ± 5% | |
ciliated cell | 3 studies | 21% ± 4% | |
dendritic cell | 3 studies | 30% ± 12% | |
abnormal cell | 3 studies | 22% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 5% | |
goblet cell | 3 studies | 16% ± 0% | |
oligodendrocyte | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 5322.98 | 258 / 258 | 100% | 33.93 | 230 / 230 |
brain | 100% | 6288.29 | 2642 / 2642 | 100% | 44.28 | 705 / 705 |
esophagus | 100% | 5622.53 | 1445 / 1445 | 100% | 21.59 | 183 / 183 |
intestine | 100% | 5457.60 | 966 / 966 | 100% | 27.74 | 527 / 527 |
kidney | 100% | 5553.22 | 89 / 89 | 100% | 36.47 | 901 / 901 |
ovary | 100% | 4966.85 | 180 / 180 | 100% | 17.12 | 430 / 430 |
pancreas | 100% | 4276.31 | 328 / 328 | 100% | 27.65 | 178 / 178 |
prostate | 100% | 5613.24 | 245 / 245 | 100% | 34.07 | 502 / 502 |
skin | 100% | 5796.55 | 1809 / 1809 | 100% | 35.93 | 472 / 472 |
stomach | 100% | 4719.20 | 359 / 359 | 100% | 24.35 | 286 / 286 |
thymus | 100% | 5932.09 | 653 / 653 | 100% | 35.07 | 605 / 605 |
uterus | 100% | 5339.89 | 170 / 170 | 100% | 28.42 | 459 / 459 |
lung | 100% | 4853.89 | 578 / 578 | 100% | 23.98 | 1154 / 1155 |
bladder | 100% | 5455.71 | 21 / 21 | 100% | 29.82 | 503 / 504 |
liver | 100% | 2632.14 | 226 / 226 | 100% | 15.58 | 405 / 406 |
breast | 100% | 5458.08 | 459 / 459 | 100% | 25.21 | 1113 / 1118 |
adipose | 100% | 5404.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 37.62 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.66 | 29 / 29 |
muscle | 100% | 10554.91 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5126.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.90 | 1 / 1 |
blood vessel | 100% | 4932.78 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 4192.26 | 858 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3372.27 | 908 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0032466 | Biological process | negative regulation of cytokinesis |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0006998 | Biological process | nuclear envelope organization |
GO_0006622 | Biological process | protein targeting to lysosome |
GO_0061764 | Biological process | late endosome to lysosome transport via multivesicular body sorting pathway |
GO_0009838 | Biological process | abscission |
GO_0034058 | Biological process | endosomal vesicle fusion |
GO_0032880 | Biological process | regulation of protein localization |
GO_0032367 | Biological process | intracellular cholesterol transport |
GO_0061640 | Biological process | cytoskeleton-dependent cytokinesis |
GO_0016236 | Biological process | macroautophagy |
GO_0044878 | Biological process | mitotic cytokinesis checkpoint signaling |
GO_0051301 | Biological process | cell division |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0061952 | Biological process | midbody abscission |
GO_0061738 | Biological process | late endosomal microautophagy |
GO_1903543 | Biological process | positive regulation of exosomal secretion |
GO_0000916 | Biological process | actomyosin contractile ring contraction |
GO_0090148 | Biological process | membrane fission |
GO_0007033 | Biological process | vacuole organization |
GO_0006997 | Biological process | nucleus organization |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0016197 | Biological process | endosomal transport |
GO_0046761 | Biological process | viral budding from plasma membrane |
GO_0007084 | Biological process | mitotic nuclear membrane reassembly |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0006900 | Biological process | vesicle budding from membrane |
GO_0019076 | Biological process | viral release from host cell |
GO_0072319 | Biological process | vesicle uncoating |
GO_1904903 | Biological process | ESCRT III complex disassembly |
GO_0006914 | Biological process | autophagy |
GO_1904896 | Biological process | ESCRT complex disassembly |
GO_1903076 | Biological process | regulation of protein localization to plasma membrane |
GO_0097352 | Biological process | autophagosome maturation |
GO_0090611 | Biological process | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_1903774 | Biological process | positive regulation of viral budding via host ESCRT complex |
GO_0030496 | Cellular component | midbody |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005643 | Cellular component | nuclear pore |
GO_0005886 | Cellular component | plasma membrane |
GO_0000922 | Cellular component | spindle pole |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_0005813 | Cellular component | centrosome |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0090543 | Cellular component | Flemming body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005770 | Cellular component | late endosome |
GO_1904949 | Cellular component | ATPase complex |
GO_0005774 | Cellular component | vacuolar membrane |
GO_0010008 | Cellular component | endosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0005634 | Cellular component | nucleus |
GO_0140545 | Molecular function | ATP-dependent protein disaggregase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | VPS4A |
Protein name | VPS4A protein Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4) |
Synonyms | VPS4 |
Description | FUNCTION: Involved in late steps of the endosomal multivesicular bodies (MVB) pathway. Recognizes membrane-associated ESCRT-III assemblies and catalyzes their disassembly, possibly in combination with membrane fission. Redistributes the ESCRT-III components to the cytoplasm for further rounds of MVB sorting. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. It is required for proper accomplishment of various processes including the regulation of endosome size, primary cilium organization, mitotic spindle organization, chromosome segregation, and nuclear envelope sealing and spindle disassembly during anaphase . Involved in cytokinesis: retained at the midbody by ZFYVE19/ANCHR and CHMP4C until abscission checkpoint signaling is terminated at late cytokinesis. It is then released following dephosphorylation of CHMP4C, leading to abscission . VPS4A/B are required for the exosomal release of SDCBP, CD63 and syndecan . Critical for normal erythroblast cytokinesis and correct erythropoiesis . .; FUNCTION: (Microbial infection) In conjunction with the ESCRT machinery also appears to function in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and enveloped virus budding (HIV-1 and other lentiviruses). . |
Accessions | ENST00000254950.13 Q49AN7 Q9UN37 |